Compared with responders who achieved a partial response after the administration of anti‐PD‐1 immunotherapy, nonresponders who demonstrated an enlargement of tumor size had higher PGAM1 and LCN2 expression as well as lower CD8 expression (Figure 6L). Here, PGAM1 is linked to neoplasm.